These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients. Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309 [TBL] [Abstract][Full Text] [Related]
13. Contrast medium-removing effect of hemofiltration and hemodiafiltration. Okahisa T; Sogabe M; Hayashi S; Shibata H; Ito S J Med Invest; 1998 Aug; 45(1-4):87-93. PubMed ID: 9864968 [TBL] [Abstract][Full Text] [Related]
14. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy]. Gong D; Ji D; Xie H; Xu B; Liu Y; Li L Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577 [TBL] [Abstract][Full Text] [Related]
15. Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients. Isla A; Maynar J; Sánchez-Izquierdo JA; Gascón AR; Arzuaga A; Corral E; Pedraz JL J Clin Pharmacol; 2005 Nov; 45(11):1294-304. PubMed ID: 16239363 [TBL] [Abstract][Full Text] [Related]
16. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes. Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177 [TBL] [Abstract][Full Text] [Related]
17. In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies. Isla A; Gascón AR; Maynar J; Arzuaga A; Sánchez-Izquierdo JA; Pedraz JL Chemotherapy; 2007; 53(3):194-201. PubMed ID: 17356270 [TBL] [Abstract][Full Text] [Related]
18. Factors affecting urea clearance during continuous hemodiafiltration in the canine model. Hiyama DT; Weiss RG; Ryckman FC J Pediatr Surg; 1989 Aug; 24(8):756-9. PubMed ID: 2769542 [TBL] [Abstract][Full Text] [Related]
19. A comparison of molecular clearance rates during continuous hemofiltration and hemodialysis with a novel volumetric continuous renal replacement system. Jeffrey RF; Khan AA; Prabhu P; Todd N; Goutcher E; Will EJ; Davison AM Artif Organs; 1994 Jun; 18(6):425-8. PubMed ID: 8060251 [TBL] [Abstract][Full Text] [Related]